News | January 03, 2024
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Marks remarkable acceleration in innovation using AI technology
Innovent will supply sintilimab for the collaborated clinical trial
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
NEIAFMR to be developed as the national hub for folk medicine
AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Subscribe To Our Newsletter & Stay Updated
